British Health Minister Matt Hancock said that the multinational pharmaceutical company AstraZeneca, which our government has signed a purchase contract with, has applied to the UK health authorities to approve the use of the COVID-19 vaccine jointly developed with Oxford University.
Minister Hancock said at a press conference on the 23rd local time, "We have submitted all clinical data to the authorities for approval of the use of the AstraZeneca vaccine developed in the UK," he said. "We are very happy to share this news."